Statistical considerations for a trial of Ebola virus disease therapeutics.

This article describes the Ebola virus disease medical countermeasures trial design and the thinking behind it. PMID: 26768567 [PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/26768567?dopt=Abstract

Source: Clinical Trials - January 14, 2016 Category: Research Authors: Proschan MA, Dodd LE, Price D Tags: Clin Trials Source Type: research